Clinical Trial Update: Identification of an Immune Single Cell Transcriptomic Profile of Responder and Non-responder Hepatocellular Carcinoma Patients Treated With Immune-checkpoint Inhibitors

View source ↗

Summary

A clinical trial is investigating an immune single-cell transcriptomic profile associated with response to immune-checkpoint inhibitors in hepatocellular carcin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immune checkpoint inhibitors (unspecified)

Snippet

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia | Conditions: Advanced HCC Treated by Systemic Immunotherapy | Status: RECRUITING